Literature DB >> 34699332

Phenotypic Heterogeneity in Chronic Obstructive Pulmonary Disease.

Malvika Kaul1, Solomon Krow1, Ai-Yui M Tan1, Sunit Singla1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34699332      PMCID： PMC8865584          DOI： 10.1164/rccm.202102-0293RR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

1.  Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction.

Authors:  Shawn D Aaron; Wan C Tan; Jean Bourbeau; Don D Sin; Robyn H Loves; Jenna MacNeil; George A Whitmore
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

2.  One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease.

Authors:  María-Teresa García-Sanz; Juan-Carlos Cánive-Gómez; Laura Senín-Rial; Jorge Aboal-Viñas; Alejandra Barreiro-García; Eva López-Val; Francisco-Javier González-Barcala
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Young and middle-aged adults with airflow limitation according to lower limit of normal but not fixed ratio have high morbidity and poor survival: a population-based prospective cohort study.

Authors:  Yunus Çolak; Shoaib Afzal; Børge G Nordestgaard; Jørgen Vestbo; Peter Lange
Journal:  Eur Respir J       Date:  2018-03-29       Impact factor: 16.671

4.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

5.  CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society.

Authors:  David A Lynch; John H M Austin; James C Hogg; Philippe A Grenier; Hans-Ulrich Kauczor; Alexander A Bankier; R Graham Barr; Thomas V Colby; Jeffrey R Galvin; Pierre Alain Gevenois; Harvey O Coxson; Eric A Hoffman; John D Newell; Massimo Pistolesi; Edwin K Silverman; James D Crapo
Journal:  Radiology       Date:  2015-05-11       Impact factor: 11.105

6.  Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.

Authors:  Marilyn G Foreman; Carla Wilson; Dawn L DeMeo; Craig P Hersh; Terri H Beaty; Michael H Cho; John Ziniti; Douglas Curran-Everett; Gerard Criner; John E Hokanson; Mark Brantly; Farshid N Rouhani; Robert A Sandhaus; James D Crapo; Edwin K Silverman
Journal:  Ann Am Thorac Soc       Date:  2017-08

7.  Low and High Blood Eosinophil Counts as Biomarkers in Hospitalized Acute Exacerbations of COPD.

Authors:  Martin Ian MacDonald; Christian R Osadnik; Lauren Bulfin; Kais Hamza; Paul Leong; Anders Wong; Paul T King; Philip G Bardin
Journal:  Chest       Date:  2019-04-09       Impact factor: 9.410

8.  Subtyping COPD by Using Visual and Quantitative CT Imaging Features.

Authors:  Jinkyeong Park; Brian D Hobbs; James D Crapo; Barry J Make; Elizabeth A Regan; Stephen Humphries; Vincent J Carey; David A Lynch; Edwin K Silverman
Journal:  Chest       Date:  2019-07-05       Impact factor: 9.410

9.  Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon.

Authors:  Belinda J Thomas; Rebecca A Porritt; Paul J Hertzog; Philip G Bardin; Michelle D Tate
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379

10.  Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene.

Authors:  Emily S Wan; Peter J Castaldi; Michael H Cho; John E Hokanson; Elizabeth A Regan; Barry J Make; Terri H Beaty; MeiLan K Han; Jeffrey L Curtis; Douglas Curran-Everett; David A Lynch; Dawn L DeMeo; James D Crapo; Edwin K Silverman
Journal:  Respir Res       Date:  2014-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.